|
Overview
The pipeline of therapeutic antibodies has been growing steadily, building on successful clinical trials, particularly
in cancer. This growth will certainly accelerate, as genomic companies with many novel targets seek to
employ antibodies to modulate these targets. In addition, studies employing antibodies, or antibody mimics, are
being ramped up as part of the explosive growth of proteomics. All of these trends place a tremendous emphasis
on the development of new approaches for faster antibody development, improved methods of selection and
optimization, alternatives for production, and evaluation for novel applications. This conference will provide you
will key updates on important developments in each of these areas.
|
Topics may include, but are not limited to:
|
|
• Improving selection of antibody targets
• Antibody modification to improve safety and
efficacy
• Case studies of clinical development
• Novel therapeutic applications
• Clinical trial status of antibodies
|
• Synthetic antibody libraries
• Novel display systems and arrays
• Advances in antibody production, including
transgenics
• Engineering and optimization
• Development of intracellular antibodies
• Protein function and localization studies |
Researchers are encouraged to submit a title and short 3-4 line summary for consideration for oral and poster
presentations. Please include full contact information for the presenter. Proposals are subject to review by the
Scientific Advisory Board.
Click
here to submit a proposal
For more information, please contact, fax or e-mail submissions to:
Elizabeth Lamb, Senior Conference Director, Cambridge Healthtech Institute
Fax: 207-493-7874 • E-mail: elamb@healthtech.com
For exhibits and sponsorship information, please contact:
Carol Dinerstein, Manager of Business Development • Phone: 781-972-5471
• E-mail: dinerstein@healthtech.com
|
